Blood Cancer United
Lore Gruenbaum is a distinguished leader in the scientific community, currently serving as the Chief Scientific Officer at Blood Cancer United since January 2025. Previously, Lore held the position of VP for the Research Therapy Acceleration Program at The Leukemia & Lymphoma Society from May 2020 to December 2024, where strategic leadership and administrative oversight were provided to advance therapeutic initiatives. Prior experience includes roles as VP of Biology at Gotham Therapeutics, Executive Director of Biology/Pharmacology at Applied BioMath, and various positions at Roche and Boehringer Ingelheim Pharmaceuticals focusing on biomarker strategy and drug discovery. Lore's academic background includes a postdoctoral fellowship in Neuroscience at Yale University and a Ph.D. in Biochemistry from Freie Universität Berlin.
This person is not in any teams
This person is not in any offices